Implementing a tenofovir-based first-line regimen in rural lesotho: clinical outcomes and toxicities after two years.


Bygrave, H; Ford, N; Cutsem, G; Hilderbrand, K; Jouquet, G; Goemaere, E; Vlahakis, N; Triviño, L; Makakole, L; Kranzer, K; (2011) Implementing a tenofovir-based first-line regimen in rural lesotho: clinical outcomes and toxicities after two years. Journal of acquired immune deficiency syndromes (1999), 56 (3). e75-8. ISSN 1525-4135 DOI: https://doi.org/10.1097/QAI.0b013e3182097505

Full text not available from this repository.

Abstract

: The latest World Health Organization guidelines recommend replacing stavudine with tenofovir or zidovudine in first-line antiretroviral therapy in resource-limited settings. We report on outcomes and toxicities among patients on these different regimens in a routine treatment cohort in Lesotho.

Item Type: Article
Faculty and Department: Faculty of Epidemiology and Population Health > Dept of Infectious Disease Epidemiology
PubMed ID: 21164354
Web of Science ID: 287864300002
URI: http://researchonline.lshtm.ac.uk/id/eprint/1354

Statistics


Download activity - last 12 months
Downloads since deposit
0Downloads
281Hits
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item